We are pleased to be attending the AAPS–USP Workshop at PharmSci 360 2026, taking place from 26th–28th October in New Orleans, USA.
Bringing together pharmaceutical scientists, industry experts and regulatory professionals, the workshop will explore the latest developments in pharmaceutical science, with a focus on evolving testing methodologies, regulatory expectations and the challenges associated with complex drug product development.
As part of the event, our Head of Business Development, Paul Martin, will be sharing work focused on addressing challenges in inhaled drug product development and testing, including early data generated using Copley’s Inhaled Dissolution Apparatus™ IDA.
The workshop provides a valuable opportunity to exchange knowledge, explore emerging scientific approaches and discuss advancements in pharmaceutical testing and quality standards.
We look forward to connecting with fellow industry professionals and contributing to discussions surrounding the future of inhaled drug product testing.
Attending the workshop? Get in touch with our team at sales@copleyscientific.co.uk to arrange a meeting during the event.
For more information on the event and to register, follow the link here.
